Henry Schein, Inc.(HSIC) Stock Research - Grey Stern Research
Loading...

Henry Schein, Inc. (HSIC) Stock Analysis

$70.49 (-1.01%)

HSIC Financial Performance


Use the table below to view Henry Schein, Inc.'s financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q2 - 2024

Metric Value Ranking among Peers
Price $71.21 -
52 Week Low $60.01 -
52 Week High $82.63 -
Market Cap $9.0 Billion 4/8
Gross Margin 30% 3/8
Profit Margin 3% 1/8
EBITDA margin 8% 1/8
Q2 - 2024 Revenue $3.1 Billion 4/8
Q2 - 2024 Earnings $104.0 Million 4/8
Q2 - 2024 Free Cash Flow $248.0 Million 2/8
Trailing 4 Quarters Revenue $12.5 Billion 4/8
Trailing 4 Quarters Earnings $352.0 Million 4/8
Quarterly Earnings Growth -26% 5/8
Annual Earnings Growth -30% 7/8
Quarterly Revenue Growth 1% 7/8
Annual Revenue Growth 2% 7/8
Cash On Hand $138.0 Million 6/8
Short Term Debt $686.0 Million 1/8
Long Term Debt $1.9 Billion 4/8

Henry Schein, Inc. Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Henry Schein, Inc.'s metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 25.63 3/8
PS 0.72 3/8
PB 1.80 5/8
PC 65.38 1/8
Liabilities to Equity 1.49 5/8
ROA 0.03 4/8
ROE 0.10 4/8
Current Ratio 1.95 2/8
Quick Ratio 0.03 7/8
Long Term Debt to Equity 0.54 4/8
Debt to Equity 0.81 5/8
Burn Rate 0.96 5/8
Cash to Cap 0.02 7/8
CCR 2.38 2/8
EV to EBITDA 47.27 3/8
EV to Revenue 0.94 3/8

Company Details

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

CEO: Mr. Stanley Bergman

Website: https://www.henryschein.com

Address: 135 Duryea Rd Melville, NEW YORK

Exchange: NASDAQ Global Select

Industry: Medical Distribution

Henry Schein, Inc. Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Henry Schein, Inc.. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
Patterson Companies, Inc. PDCO $1.8 Billion
McKesson Corporation MCK $63.4 Billion
AmerisourceBergen Corporation ABC $36.1 Billion
Cardinal Health, Inc. CAH $26.7 Billion
Owens & Minor, Inc. OMI $1.1 Billion
EDAP TMS S.A. EDAP $97.6 Million
Zynex, Inc. ZYXI $252.4 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
HSIC Income Statements
Quarter Year Revenue Earnings
Q2 2024 $ 3.1 Billion $104.0 Million
Q1 2024 $ 3.2 Billion $93.0 Million
Q4 2023 $ 3.0 Billion $18.0 Million
Q3 2023 $ 3.2 Billion $137.0 Million
Q2 2023 $ 3.1 Billion $140.0 Million
Q1 2023 $ 3.1 Billion $121.0 Million
Q4 2022 $ 3.4 Billion $47.0 Million
Q3 2022 $ 3.1 Billion $150.0 Million

View All

HSIC Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q2 2024 $138.0 Million $10.3 Billion $2.8 Billion $5.0 Billion
Q1 2024 $159.0 Million $10.1 Billion $2.7 Billion $5.0 Billion
Q4 2023 $171.0 Million $10.6 Billion $2.7 Billion $5.2 Billion
Q3 2023 $166.0 Million $9.8 Billion $0 $5.1 Billion
Q2 2023 $137.0 Million $9.1 Billion $1.9 Billion $3.6 Billion
Q1 2023 $126.0 Million $8.6 Billion $1.7 Billion $3.5 Billion
Q4 2022 $117.0 Million $8.6 Billion $1.5 Billion $3.4 Billion
Q3 2022 $123.0 Million $8.5 Billion $1.4 Billion $3.6 Billion

View All

HSIC Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q2 2024 $248.0 Million -$48.0 Million -$21.0 Million
Q1 2024 $147.0 Million -$50.0 Million -$12.0 Million
Q4 2023 -$111.0 Million -$79.0 Million $5.0 Million
Q3 2023 $191.0 Million -$40.0 Million $29.0 Million
Q2 2023 $237.0 Million -$37.0 Million $11.0 Million
Q1 2023 -$4.0 Million -$31.0 Million $9.0 Million
Q4 2022 $225.0 Million -$29.0 Million -$6.0 Million
Q3 2022 $74.0 Million -$24.0 Million $15.0 Million

View All